微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 1.08% | -70.49% | -90.51% | 86/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | 11.38% | 162.82% | 40.49% | 21/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | 8.1% | 14.08% | 530.85% | 33/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -1.88% | -157.85% | -151.37% | 119/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 3.66% | 22% | -15.47% | 23/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | 4.33% | 233.64% | -39.01% | 64/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | 7.1% | 394.61% | 118.46% | 48/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | 3.25% | 151.1% | 8.33% | 58/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 3% | 889.47% | 192.59% | 36/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -3.24% | 86.54% | -34.44% | 112/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -2.41% | 39.75% | 62.11% | 120/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -6.36% | 10.3% | -1573.68% | 128/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | -0.38% | -46.15% | 98.42% | 120/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -24.08% | -15.94% | -502% | 135/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | -4% | -406.33% | 43.58% | 120/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | -7.09% | -79.49% | -2626.92% | 134/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | -0.26% | -273.33% | 98.75% | 114/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | -20.77% | 48.09% | -2529.11% | 133/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | -0.79% | 95.19% | 80% | 114/157 | 4.46% | XDST人福 | 6.82% | 行业排名> |
| 2021-06-30 | -3.95% | 65.29% | -2733.33% | 124/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 0.15% | 102.73% | 100.37% | 107/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | -40.01% | -448.83% | -143.81% | 136/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | -16.41% | -408.46% | -44.2% | 111/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | -11.38% | -1238% | -106.91% | 123/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | -5.5% | -323.58% | 24.55% | 107/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | -7.29% | -331.36% | -237.03% | 119/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 5.32% | 99.25% | 432% | 63/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 1% | -41.86% | -59.35% | 97/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 2.46% | 176.4% | 245.56% | 44/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | -1.69% | -522.5% | -163.3% | 121/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 2.67% | -9.18% | 55.23% | 84/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 1.72% | -27.43% | 93.26% | 85/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 0.89% | 12.66% | 122.5% | 80/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 0.4% | -48.72% | -86.39% | 115/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 2.94% | -19.45% | 24.05% | 77/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 2.37% | -2.47% | 200% | 77/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 0.79% | -5.95% | 1.28% | 66/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 0.78% | -74.26% | -78.63% | 98/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 3.65% | -17.98% | 50.21% | 63/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 2.43% | -14.13% | 189.29% | 62/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 0.84% | -24.32% | -72.28% | 59/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |